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Coronary  artery  aneurysms  in  patients  with  Behc¸ et’s  disease  are rare  and  associated  with  fatal  complica-
tions.  Covered  stents  have  been  used  in  the management  of  coronary  aneurysms  but not  in patients  with
Behc¸ et’s  disease.  We  are  reporting  a rare case  of Behc¸ et’s  disease,  admitted  with  non-ST  segment  eleva-
tion  myocardial  infarction,  whose  coronary  angiogram  revealed  huge  aneurysm  involving proximal  left
anterior  descending  artery  followed  by severe  stenosis.  The  stenosis  was  treated  by drug-eluting  stentehc¸ et’s disease
oronary artery aneurysm
overed stents
and the  aneurysm  was  successfully  sealed  with a covered  stent.  He  remained  asymptomatic  at  3-month
follow-up  and  repeat  angiogram  showed  patent  stents.
<Learning  objective:  There  is  no  consensus  upon  the  management  of coronary  artery  aneurysm  in
a  patient  with  Behc¸ et’s  disease  presenting  with  acute  myocardial  infarction.  Sealing  of  aneurysm  with
covered  stent  and  managing  stenosis  with  drug-eluting  stent  can  also be used  for  management  in  these
patients  with  adequate  use  of immunosuppressant  and  anticoagulant.>
3  Jap© 201
ntroduction
Behc¸ et’s disease is a systemic vasculitic syndrome with a wide
ariety of clinical manifestations. Arterial aneurysms and pseudoa-
eurysms are reported with Behc¸ et’s disease but coronary artery
neurysms are rare and associated with fatal complications [1].
overed stents have been used in the management of coronary
neurysms, but not in patients with Behc¸ et’s disease. We  are report-
ng a rare case of a middle-aged man  diagnosed with Behc¸ et’s dis-
ase, admitted with non-ST segment elevation myocardial infarc-
ion (NSTEMI). His coronary angiogram revealed huge aneurysm
nvolving proximal left anterior descending (LAD) artery followed
y severe stenosis and was successfully managed with covered and
rug-eluting stents. He maintained an asymptomatic course and
ngiogram after 3 months revealed patent stents. We  will discuss
he clinical presentation and treatment options in our report.
ase reportA 39-year-old man  with hypertension, dyslipidemia, and hyper-
ricemia developed recurrent oral, genital ulcers and polyarthritis.
e complained of headache, blurring of vision and was found
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to have bilateral papilledema in August 2011. His brain imaging
showed superior sagittal and transverse sinus thrombosis with-
out any evidence of vascular aneurysm. His thrombophilic workup
was negative for hypercoagulable state. He was  diagnosed with
Behc¸ et’s disease and started on hydrochloroquine and warfarin
with follow-up in the rheumatology clinic. He presented in May
2012 with recurrent episodes of chest pain and positive cardiac tro-
ponin I. His electrocardiogram showed normal sinus rhythm with
nonspeciﬁc T wave inversion in avL and echocardiogram revealed
normal left ventricular systolic function. His coronary angiogram
showed huge mid  LAD aneurysm followed by severe stenosis (Fig. 1
a and b). No other aneurysm or stenosis was detected. Percuta-
neous coronary intervention (PCI) was  carried out by using Extra
Back-Up (EBU, Medtronic, Minneapolis, MN,  USA) guiding catheter
for engaging left main coronary artery. High torque Balance Mid-
dleweight Universal (BMW,  Abbott, IL, USA) guide wire was used
for crossing the lesion and aneurysm. Proximal severe stenosis was
dilated with 2 mm  × 20 mm Trek balloon up to 20 atm followed by
stenting with 3 mm × 24 mm Promus Element (Boston Scientiﬁc,
Natick, MA,  USA) at 12 atm. His huge proximal aneurysm was sealed
by 3.5 mm × 16 mm Graft Master covered stent (Abbott Vascular
Devices, Santa Clara, CA, USA) and dilated with 3.5 mm × 20 mm NC
Trek balloon up to 22 atm. A 3.5 mm × 12 mm Graft Master covered
stent was deployed proximal to the previous covered stent with
minimal overlap and dilated with 3.5 mm × 12 mm NC Trek bal-
loon up to 12 atm (Fig. 1c–e). His post PCI hospital course remained
unremarkable. He was  continued on aspirin, clopidogrel, and
vier Ltd. All rights reserved.
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ngioplasty. (c)–(e) Coronary angiogram after angioplasty showing sealed aneurysm
arfarin along with other medications. He was prescribed intra-
enous injections of methyl prednisolone and cyclophosphamide
ollowed by oral prednisolone at discharge in compliance with
heumatology advice. He remained asymptomatic at follow-up
fter 3 months and repeat angiogram showed patent stents (Fig. 2a
nd b).
iscussion
Behc¸ et’s disease is a chronic relapsing inﬂammatory process
haracterized by recurrent oral and genital aphtous ulcers, eye
nﬂammation, skin eruption, vasculitis, arthritis, and neurologi-
al manifestation [1]. Our patient had recurrent oral and genital
lcers, arthritis, and subsequently complained of headache and
rogressive reduction in vision. He was found to have bilateraling artery (LAD) followed by tight stenosis in different cranial angulations before
 stented mid  LAD segment in different angulations.
papilledema and magnetic resonance venogram showed sagittal,
transverse sinus thrombosis. Venous thrombosis is more common
than arterial involvement [1]. His condition improved after initia-
tion of anticoagulation and acetazolamide. Cardiac manifestations
such as pericarditis, cardiomyopathy, endocarditis, endomyocar-
dial ﬁbrosis, intracavitary thrombosis, and valvular disease occur in
5% of patients [2]. Coronary artery disease and coronary aneurysm
are extremely rare and seldom reported with male preponderance
[3–5]. Vascular occlusion and obstruction were seen more fre-
quently than aneurysm [4–6]. The possible etiologies of myocardial
infarction in patients with Behc¸ et’s disease are coronary vasculitis,
atherosclerosis, and plaque rupture.Treatment of coronary artery disease in such patients is very
challenging. Anticoagulant therapy was changed for a platelet
aggregant despite history of venous thrombosis upon discovery
of coronary aneurysm and surgery was  not done because of the
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wFig. 2. (a) and (b) Coronary angiogram after 3 m
ragility of the vessels [7]. Medical treatment alone with steroid
nd immunosuppression failed to keep the vessel patent in a
atient with right coronary artery aneurysm and tight stenosis
ho presented three years later with total occlusion [8]. Steroid
nd warfarin were initiated for a patient who developed aneurysm
roximal to the stent of right coronary artery after myocardial
nfarction [9]. Surgical treatment for LAD aneurysm was  consid-
red in a patient with distal left main aneurysm. Covered stent was
uccessfully used in a reported case of a young man  for treatment
f coronary aneurysm [10]. These case reports showed diversiﬁca-
ion in treatment ranging from platelet aggregant to warfarin and
rom medical management to surgical resection or percutaneous
reatment. We  treated our patient with steroid, dual antiplatelets,
nd low molecular weight heparin as he had recurrent symptoms
nd positive cardiac enzyme. Pseudoaneurysm could be a possibil-
ty but no imaging study was done to differentiate between true
r pseudo aneurysm. There is no consensus statement for treat-
ent of coronary aneurysm and the best modality for treatment
f coronary aneurysm still needs to be deﬁned. The decision to
roceed with percutaneous treatment was made after discussion
n a joint meeting with cardiac surgeons and considering his age,
hich made it likely that he would have to endure a second pro-
edure and bypass surgery was kept as a backup plan. Covered
tent was selected to prevent future complications such as throm-
us formation, risk of myocardial infarction, rupture, and due to its
vidence of successful placement in multiple case reports [10,11]
nd case series [12]. There was no in-hospital major adverse cardiac
vent after use of covered stent and only one patient (14%) had in-
tent restenosis during 3 years of follow up that required another
CI [12]. The available data on the use of covered stents for coronary
neurysm are encouraging although more data are needed. Other
ypes of stents, including bare metal [13], were rarely used for coro-
ary aneurysms and the majority of evidence is for covered stents.
e informed the patient regarding available treatment modalities
nd decided for percutaneous treatment with covered stent after
is consent. PCI of mid  LAD was done with a drug-eluting stent
o reduce the chances of in-stent restenosis. There have been case
eports using covered stents and drug-eluting stents to reduce the
isk of in-stent restenosis [14]. Pseudoaneurysm can also develop
fter drug-eluting stent placement as reported by Alex et al., ﬁve
onths after its implantation for inferior ST elevation myocardial
nfarction along with femoral and left ventricular pseudoaneurysm
15]. Our patient will continue on dual antiplatelet therapy and
arfarin for at least one year followed by aspirin and warfarin,
[ showing patent stents in different angulations.
while steroid and immunosuppressive medication will be tailored
in accordance with rheumatologists. Patients with Behc¸ et’s disease
are predisposed to further risk of aneurismal formation and throm-
bosis after implantation of drug-eluting and covered stents. Our
patient remained ﬁne at 3 months follow-up and repeat coronary
angiogram did not show any new abnormality. He will be followed
in the cardiology clinic with imaging studies.
Conclusion
This case report highlighted the presence of venous throm-
bosis, arterial aneurysm, and stenosis in a patient with Behc¸ et’s
disease. Covered stents can be used successfully for sealing coro-
nary aneurysms along with drug-eluting stents for tight lesions in
patients with Behc¸ et’s disease presenting with NSTEMI.
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